The Business Research Company’s Rhinovirus Diagnostics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, July 22, 2026 /EINPresswire.com/ — “The rhinovirus diagnostics market has been gaining significant traction recently, driven by advances in technology and an increasing need for accurate respiratory infection testing. As respiratory illnesses continue to impact global health, this market is poised for notable expansion. Below is a detailed overview of its current status, key growth drivers, major players, emerging trends, and regional dynamics.
Rhinovirus Diagnostics Market Size and Growth Outlook
The rhinovirus diagnostics market has exhibited strong expansion in recent years. It is projected to rise from $1.58 billion in 2025 to $1.71 billion in 2026, representing a compound annual growth rate (CAGR) of 7.9%. This upward trend during the historical period is largely due to the growing incidence of common colds and respiratory infections worldwide, increased adoption of molecular diagnostic methods for viral detection, improvements in hospital lab testing facilities, the limitations of traditional virus culture techniques, and heightened awareness about early infectious disease diagnosis.
Download a free sample of the rhinovirus diagnostics market report:
https://www.thebusinessresearchcompany.com/sample_request?id=98234556&type=smp&name=Rhinovirus%20Diagnostics%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Looking ahead, the market is expected to continue its robust growth trajectory, reaching $2.33 billion by 2030 at a CAGR of 8.2%. Factors propelling this forecast include a rising demand for rapid point-of-care diagnostic tests, incorporation of AI-driven diagnostic interpretation tools, expansion of multiplex testing panels that detect multiple respiratory pathogens, increased investment in infectious disease monitoring systems, and advances in personalized and precision medicine strategies for respiratory conditions. Key trends anticipated during this period involve AI-enhanced rapid respiratory pathogen identification, broader use of multiplex PCR respiratory virus panels, growth in point-of-care rhinovirus diagnostic devices, adoption of cloud-based infectious disease surveillance platforms, and development of highly sensitive molecular assays for early detection.
Understanding Rhinovirus Diagnostics and Their Role
Rhinovirus diagnostics encompass laboratory and clinical testing procedures used to detect and confirm rhinovirus infections, which are the primary cause of the common cold. These diagnostic tests typically analyze respiratory samples employing sophisticated molecular technologies to ensure fast and precise virus identification. Such diagnostics are crucial in aiding healthcare professionals to make timely treatment choices, effectively manage infection spread, and improve patient outcomes in respiratory illness care.
View the full rhinovirus diagnostics market report:
https://www.thebusinessresearchcompany.com/report/rhinovirus-diagnostics-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Key Factors Driving Rhinovirus Diagnostics Market Growth
An increasing prevalence of respiratory disorders is a significant factor fueling the expansion of the rhinovirus diagnostics market. Respiratory disorders affect the lungs and airways, impairing breathing and oxygen exchange. These conditions are on the rise, mainly due to worsening air pollution that damages lung function through prolonged exposure to harmful substances, thereby weakening respiratory health over time. Rhinovirus diagnostics play a vital role by enabling prompt detection of rhinovirus infections, which supports accurate treatment decisions, prevents complications, and reduces transmission of respiratory diseases. For example, in December 2023, the National Center for Biotechnology Information, a US government agency, reported that Chronic Obstructive Pulmonary Disease (COPD) cases are projected to increase by 112 million, reaching 592 million by 2050, which would represent 9.5% of the total eligible population. This surge in respiratory disorders directly contributes to the growing demand for rhinovirus diagnostic tools.
Healthcare Spending Trends Encouraging Market Expansion
Rising healthcare expenditure is another important driver behind the growth of the rhinovirus diagnostics market. Healthcare expenditure refers to the total financial resources allocated by individuals, organizations, and governments toward the prevention, treatment, and management of health conditions. This spending has been increasing due to technological advancements, as new diagnostic tools, treatments, and innovative therapies often come with higher costs, leading to overall greater healthcare investment. Increased healthcare expenditure facilitates better access to advanced diagnostic technologies, enhances diagnostic infrastructure, and improves patient affordability and testing rates. For instance, in April 2025, the Office for National Statistics in the UK reported that healthcare spending in 2024 reached approximately $29.88 billion (£317 billion), marking a 6.5% nominal rise compared to 2023. This upward trend in healthcare funding supports the expanding need for rhinovirus diagnostics worldwide.
Regional Market Leadership and Growth Prospects
In 2025, North America held the largest share of the rhinovirus diagnostics market. Meanwhile, the Asia-Pacific region is expected to see the fastest growth during the forecast period. The market analysis covers regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on the market’s expansion and regional opportunities.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at marketing@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company “
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
